ENERGIZER HOLDINGS, INC. DECLARES QUARTERLY DIVIDEND ON ITS COMMON STOCK
ST. LOUIS, April 29, 2024 /PRNewswire/ -- Energizer Holdings, Inc. (NYSE: ENR) announced that its Board of Directors declared a dividend on its common stock of $0.30 per share. The dividend will be payable on June 12, 2024 to shareholders of record as of the close of business on May 22, 2024.
About Energizer Holdings, Inc.
Energizer Holdings, Inc. ("Energizer", NYSE: ENR), headquartered in St. Louis, Missouri, is one of the world's largest manufacturers and distributors of primary batteries, portable lights, and auto care appearance, performance, refrigerant, and fragrance products. Our portfolio of globally recognized brands includes Energizer®, Armor All®, Eveready®, Rayovac®, STP®, Varta®, A/C Pro®, Refresh Your Car!®, California Scents®, Driven®, Bahama & Co.®, LEXOL®, Eagle One®, Nu Finish®, Scratch Doctor®, and Tuff Stuff®. As a global branded consumer products company, Energizer's mission is to lead the charge to deliver value to our customers and consumers better than anyone else. Visit www.energizerholdings.com for more details.
Jackson Nurse Professionals, a premier travel nurse staffing agency, today announced its new partnership with Immediate, an innovative earned wage access provider. By introducing Immediate's cutting-edge financial benefit to its network of travel...
TaskUs, Inc. , a leading provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, today announced that Bryce Maddock, Co-Founder and CEO will participate in the following investor...
Next week at Dell TechnologiesTM World, KIOXIA, the inventor of NAND flash memory, will highlight its extensive, diverse portfolio of solid state drives (SSDs) and memory solutions. Enabling a wide spectrum of applications requiring flash storage,...
Protolabs , provider of the fastest and most comprehensive digital manufacturing service in the world, today announced that the company will present at the following two upcoming conferences:
The Manufacturing Leadership Council's ?Rethink:...
Zephyr AI, Inc., a high-growth healthcare technology company committed to developing artificial intelligence (AI) solutions to democratize precision medicine, has announced that veteran biotechnology executive John Applegate has joined the company as...
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced dosing of the first patient in the Phase 1 clinical trial of A2B694. The multi-center...
